Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Thyroid cancer
Stage/Subtype:  stage I papillary thyroid cancer
Trial Type:  Treatment
Results 1-5 of 5 for your search:
Start Over
Dabrafenib with or without Trametinib in Treating Patients with Recurrent Thyroid Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU 12064, NCI-2012-01700, NCCNGSK20008, 2012C0074, NCT01723202
Cabozantinib-S-Malate in Treating Patients with Refractory Thyroid Cancer
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9312, NCI-2013-00554, 2012C0101, RU241210I, OSU 12154, NCT01811212
Thyroid Gland Removal with or without Central Lymph Node Dissection in Treating Patients with Node Negative Thyroid Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 21 to 70
Trial IDs: UW13115, NCI-2014-00833, 2014-0391, NCT02138214
Total Thyroidectomy with or without Prophylactic Central Neck Lymph Node Dissection in Treating Patients with Low-Risk Papillary Thyroid Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: Over 18
Trial IDs: 15-C-0105, NCI-2015-00583, 150105, P141680, NCT02408887
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Start Over